Detalhe da pesquisa
1.
Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine.
Pediatr Infect Dis J
; 38(4): 439-443, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30882742
2.
A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months.
Pediatr Infect Dis J
; 36(2): 209-215, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846055
3.
A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.
Vaccine
; 34(33): 3810-6, 2016 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27288217
4.
What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?
Patient Prefer Adherence
; 9: 1517-24, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26604704
5.
Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study.
Vaccine
; 33(32): 3976-82, 2015 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092310